Journals and Databases

Start a new search

Healthcare Databases Advanced Search | Help

 

Searched: Antiretroviral Therapy, Highly Active. Total records matched: 3035

Resources searched: MEDLINE from PubMed

  1. 1. Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy.

    Author(s): Eichler K, Bickel T, Klauke S, Eisen J, Vogl T, Zangos S

    Citation: International journal of STD & AIDS, 18 August 2014, 0956-4624

    Publication Date: 18 August 2014

    Source: MEDLINE from PubMed

  2. 2. Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis.

    Author(s): Liu H, Ma Y, Su Y, Smith MK, Liu Y, Jin Y, Gu H, Wu J, Zhu L, Wang N

    Citation: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 22 July 2014, 1058-4838

    Publication Date: 22 July 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at Oxford University Press NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License: Only available from an NHS networked computer

  3. 3. Body mass index changes during highly active antiretroviral therapy in Nigeria.

    Author(s): Denue BA, Ikunaiye PN, Denue CB

    Citation: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 09 January 2014(S89-97), 1020-3397

    Publication Date: 09 January 2014

    Source: MEDLINE from PubMed

  4. 4. Prevalence of Transmitted HIV-1 Drug Resistance Remains Low in Guangxi, China, Eight Years after Scale-Up of Highly-Active Antiretroviral Therapy.

    Author(s): Li G, Liang S, Harrison TJ, Tang Z, Shen Z, Wang X, Wu X, Liu W, Liang F, Feng L, Yang J, Fang Z

    Citation: Intervirology, 2014, vol./is. 57/5(270-6), 0300-5526

    Publication Date: 2014

    Source: MEDLINE from PubMed

  5. 5. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.

    Author(s): Gresele P, Falcinelli E, Momi S, Francisci D, Baldelli F

    Citation: Reviews in cardiovascular medicine, 2014(S9-20), 1530-6550

    Publication Date: 2014

    Source: MEDLINE from PubMed

  6. 6. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era.

    Author(s): D'Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omedè P, Grosso Marra W, Abbate A, Bonora S, Biondi Zoccai G, Moretti C, Gaita F

    Citation: Journal of cardiovascular medicine (Hagerstown, Md.), 28 June 2014, 1558-2027

    Publication Date: 28 June 2014

    Source: MEDLINE from PubMed

  7. 7. A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).

    Author(s): Lertcheewakarn P, Tongprasert F

    Citation: Journal of the Medical Association of Thailand = Chotmaihet thangphaet, April 2014, vol./is. 97/4(361-8), 0125-2208

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  8. 8. Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy.

    Author(s): Bosamiya SS, Vaishnani JB, Momin AM

    Citation: Indian journal of sexually transmitted diseases, January 2014, vol./is. 35/1(73-5), 0253-7184

    Publication Date: January 2014

    Source: MEDLINE from PubMed

  9. 9. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.

    Author(s): Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT

    Citation: BMC pharmacology & toxicology, 23 June 2014(32),

    Publication Date: 23 June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at BioMedCentral

  10. 10. Impacts of highly active antiretroviral therapy (HAART) on metabolic status of patients with AIDS: What happens from the initiation of AIDS to the initiation of treatment?

    Author(s): Abdollahi A, Shoar S, Jafari S, Shoar N

    Citation: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, March 2014, vol./is. 19/3(246-50), 1735-1995

    Publication Date: March 2014

    Source: MEDLINE from PubMed

  11. 11. Predicting Mortality in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in a Resource-Deprived Setting.

    Author(s): Nugent J, Edmonds A, Lusiama J, Thompson D, Behets F

    Citation: The Pediatric infectious disease journal, 18 June 2014, 0891-3668

    Publication Date: 18 June 2014

    Source: MEDLINE from PubMed

  12. 12. Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria.

    Author(s): Ikpeme EE, Etukudo OM, Ekrikpo UE

    Citation: African health sciences, December 2013, vol./is. 13/4(955-61), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  13. 13. Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria.

    Author(s): Afolabi BA, Afolabi MO, Afolabi AA, Odewale MA, Olowookere SA

    Citation: African health sciences, December 2013, vol./is. 13/4(920-6), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  14. 14. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.

    Author(s): Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, Zhang L, Liu Z, Liang H, Tao R

    Citation: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 14 June 2014, 0904-2512

    Publication Date: 14 June 2014

    Source: MEDLINE from PubMed

  15. 15. Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control study.

    Author(s): Obirikorang C, Osakunor DN, Ntaadu B, Adarkwa OK

    Citation: PloS one, 2014, vol./is. 9/6(e99469),

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  16. 16. Response to letter 'Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field'.

    Author(s): Mathes T, Pieper D, Antoine SL, Eikermann M

    Citation: HIV medicine, July 2014, vol./is. 15/6(383-4), 1464-2662

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  17. 17. Poor citation, coding and reporting: a review of adherence-enhancing interventions for highly active antiretroviral therapy creates an inaccurate picture of the state of the field.

    Author(s): de Bruin M, Simoni J, Amico KR, Parsons JT, Fisher J, Safren SA

    Citation: HIV medicine, July 2014, vol./is. 15/6(381-2), 1464-2662

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  18. 18. Highly active antiretroviral therapy during gestation: effects on a rat model of pregnancy.

    Author(s): F CL, Simões RS, Araujo Júnior Corresponding Author E, Oliveira Filho RM, Kulay Júnior L, Nakamura MU

    Citation: Ceska gynekologie / Ceska lekarska spolecnost J. Ev. Purkyne, April 2014, vol./is. 79/2(128-33), 1210-7832

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  19. 19. Autonomic neuropathy resulting in recurrent laryngeal nerve palsy in an HIV patient with Hodgkin lymphoma receiving vinblastine and highly active antiretroviral therapy.

    Author(s): Cherif S, Danino S, Yoganathan K

    Citation: International journal of STD & AIDS, 14 May 2014, 0956-4624

    Publication Date: 14 May 2014

    Source: MEDLINE from PubMed

  20. 20. Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients.

    Author(s): Zhu H, Yuan J, Wang Y, Gao F, Wang X, Wei C, Chen J, Fan X, Zhang M

    Citation: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 10 May 2014, 1413-8670

    Publication Date: 10 May 2014

    Source: MEDLINE from PubMed

  21. 21. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.

    Author(s): Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P

    Citation: The Lancet. Infectious diseases, July 2014, vol./is. 14/7(563-71), 1473-3099

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  22. 22. Immunologic effect of zinc supplementation in HIV-infected children receiving highly active antiretroviral therapy: a randomized, double-blind, placebo-controlled trial.

    Author(s): Lodha R, Shah N, Mohari N, Mukherjee A, Vajpayee M, Singh R, Singla M, Saini S, Bhatnagar S, Kabra SK

    Citation: Journal of acquired immune deficiency syndromes (1999), 01 August 2014, vol./is. 66/4(386-92), 1525-4135

    Publication Date: 01 August 2014

    Source: MEDLINE from PubMed

  23. 23. Prevalence and determinants of adherence to highly active antiretroviral therapy amongst people living with HIV/AIDS in a rural setting in south-south Nigeria.

    Author(s): Oku AO, Owoaje ET, Oku OO, Monjok E

    Citation: African journal of reproductive health, March 2014, vol./is. 18/1(133-43), 1118-4841

    Publication Date: March 2014

    Source: MEDLINE from PubMed

  24. 24. Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012.

    Author(s): Palladino C, Briz V, Bellón JM, Climent FJ, de Ory SJ, Mellado MJ, Navarro ML, Ramos JT, Taveira N, de José MI, Muñoz-Fernández MÁ

    Citation: PloS one, 2014, vol./is. 9/5(e96307),

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  25. 25. Edematous lip in a HIV patient on highly active antiretroviral therapy.

    Author(s): Thorpe R, Lopez I, Tran K

    Citation: Dermatology online journal, 16 April 2014, vol./is. 20/4(22370),

    Publication Date: 16 April 2014

    Source: MEDLINE from PubMed

  26. 26. Immune reconstitution inflammatory syndrome-Unmasking endophthalmic, lymphadenopathic, and neuromeningeal cryptococcosis in an HIV-infected patient starting highly active antiretroviral therapy.

    Author(s): Martinez-Zapico A, Asensi V, Fuentes N, Fonollá M, Rodriguez M, Cárcaba V, Carton JA

    Citation: AIDS research and human retroviruses, May 2014, vol./is. 30/5(434-5), 0889-2229

    Publication Date: May 2014

    Source: MEDLINE from PubMed

  27. 27. African ancestry influences CCR5 -2459G>A genotype-associated virologic success of highly active antiretroviral therapy.

    Author(s): Cheruvu VK, Igo RP Jr, Jurevic RJ, Serre D, Zimmerman PA, Rodriguez B, Mehlotra RK

    Citation: Journal of acquired immune deficiency syndromes (1999), 01 May 2014, vol./is. 66/1(102-7), 1525-4135

    Publication Date: 01 May 2014

    Source: MEDLINE from PubMed

  28. 28. The prevalence of antiretroviral multidrug resistance in highly active antiretroviral therapy-treated patients with HIV/AIDS between 2004 and 2009 in South Korea.

    Author(s): Choi JY, Kwon OK, Choi BS, Kee MK, Park M, Kim SS

    Citation: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, June 2014, vol./is. 60/2(154-60), 1386-6532

    Publication Date: June 2014

    Source: MEDLINE from PubMed

  29. 29. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy-era.

    Author(s): Munier AL, de Lastours V, Porcher R, Donay JL, Pons JL, Molina JM

    Citation: International journal of STD & AIDS, 27 March 2014, 0956-4624

    Publication Date: 27 March 2014

    Source: MEDLINE from PubMed

  30. 30. An AIDS-defining neoplasm in a 30-year-old man on highly active antiretroviral therapy: a forgotten diagnosis?

    Author(s): Russell MD, Singh-Ranger D, Crosbie J

    Citation: BMJ case reports, 26 March 2014,

    Publication Date: 26 March 2014

    Source: MEDLINE from PubMed

  31. 31. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study.

    Author(s): Enawgaw B, Alem M, Addis Z, Melku M

    Citation: BMC hematology, 25 March 2014, vol./is. 14/1(8),

    Publication Date: 25 March 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at Springer NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License. Please when asked to pick an institution please pick NHS. Please also note access is from 1997 to date only.

    Available in fulltext at Springer NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License. Please when asked to pick an institution please pick NHS. Please also note access is from 1997 to date only.

    Available in fulltext at BioMedCentral

  32. 32. Treatment Response in Association with Adherence Patterns to Highly Active Antiretroviral Therapy in Pediatric Patients with Perinatally Acquired HIV Infection.

    Author(s): Malhotra A, Whitley-Williams PN, Gaur S, Petrova A

    Citation: Journal of the International Association of Providers of AIDS Care, 17 March 2014, 2325-9574

    Publication Date: 17 March 2014

    Source: MEDLINE from PubMed

  33. 33. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals.

    Author(s): Zoufaly A, Kiepe J, Hertling S, Hüfner A, Degen O, Feldt T, Schmiedel S, Kurowski M, van Lunzen J

    Citation: HIV medicine, September 2014, vol./is. 15/8(449-57), 1464-2662

    Publication Date: September 2014

    Source: MEDLINE from PubMed

  34. 34. Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia.

    Author(s): Hejazi N, Huang MS, Lin KG, Choong LC

    Citation: Global journal of health science, 01 December 2013, vol./is. 6/2(58-71), 1916-9736

    Publication Date: 01 December 2013

    Source: MEDLINE from PubMed

  35. 35. Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India.

    Author(s): Saha R, Saha I, Sarkar AP, Das DK, Misra R, Bhattacharya K, Roy RN, Bhattacharya A

    Citation: Singapore medical journal, February 2014, vol./is. 55/2(92-8), 0037-5675

    Publication Date: February 2014

    Source: MEDLINE from PubMed

  36. 36. Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study.

    Author(s): Mu W, Zhao Y, Sun X, Ma Y, Yu L, Liu X, Zhao D, Dou Z, Fang H, Zhang F

    Citation: AIDS care, 2014, vol./is. 26/9(1127-35), 0954-0121

    Publication Date: 2014

    Source: MEDLINE from PubMed

  37. 37. Assessing baseline religious practices and beliefs to predict adherence to highly active antiretroviral therapy among HIV-infected persons.

    Author(s): Vyas KJ, Limneos J, Qin H, Mathews WC

    Citation: AIDS care, 2014, vol./is. 26/8(983-7), 0954-0121

    Publication Date: 2014

    Source: MEDLINE from PubMed

  38. 38. Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy.

    Author(s): Macarthur RD

    Citation: The American journal of managed care, September 2013, vol./is. 19/12 Suppl(s238-45), 1088-0224

    Publication Date: September 2013

    Source: MEDLINE from PubMed

  39. 39. The Association between Yang-Deficient Constitution and Clinical Outcome of Highly Active Antiretroviral Therapy on People Living with HIV.

    Author(s): Cen Y, Leung RK, Zhang F, Jia W, Zhang J, Tan X, Xu F

    Citation: Evidence-based complementary and alternative medicine : eCAM, 2013(201857), 1741-427X

    Publication Date: 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  40. 40. Vitamin A and beta-carotene concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.

    Author(s): Kaio DJ, Rondó PH, Souza JM, Firmino AV, Luzia LA, Segurado AA

    Citation: Journal of nutritional science and vitaminology, 2013, vol./is. 59/6(496-502), 0301-4800

    Publication Date: 2013

    Source: MEDLINE from PubMed

  41. 41. A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.

    Author(s): Rudek MA, Moore PC, Mitsuyasu RT, Dezube BJ, Aboulafia D, Gerecitano J, Sullivan R, Cianfrocca ME, Henry DH, Ratner L, Haigentz M Jr, Dowlati A, Little RF, Ivy SP, Deeken JF

    Citation: Cancer, 15 April 2014, vol./is. 120/8(1194-202), 0008-543X

    Publication Date: 15 April 2014

    Source: MEDLINE from PubMed

  42. 42. Sclerosing cholangitis by cytomegalovirus in highly active antiretroviral therapy era.

    Author(s): Hidalgo-Tenorio C, Blasco-Morente G

    Citation: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, October 2013, vol./is. 105/9(557-60), 1130-0108

    Publication Date: October 2013

    Source: MEDLINE from PubMed

  43. 43. Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women.

    Author(s): Kim SC, Messing S, Shah K, Luque AE

    Citation: Infectious diseases in obstetrics and gynecology, 2013(784718), 1064-7449

    Publication Date: 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  44. 44. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

    Author(s): Ngemu EK, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E

    Citation: BMC research notes, 21 January 2014(52),

    Publication Date: 21 January 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at Springer NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License. Please when asked to pick an institution please pick NHS. Please also note access is from 1997 to date only.

    Available in fulltext at Springer NHS Pilot 2014 (NESLi2); Note: ; Collection notes: Academic-License. Please when asked to pick an institution please pick NHS. Please also note access is from 1997 to date only.

  45. 45. Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

    Author(s): Wanless RS, Rugină S, Ruţă SM, Dumitru IM, Cernat RC, Schwarzwald HL, Calles NR, Schutze GE, Schweitzer AM, Draper HR, Kline MW

    Citation: Germs, 01 September 2013, vol./is. 3/3(90-5),

    Publication Date: 01 September 2013

    Source: MEDLINE from PubMed

  46. 46. Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

    Author(s): Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr

    Citation: Journal of acquired immune deficiency syndromes (1999), 01 January 2014, vol./is. 65/1(57-64), 1525-4135

    Publication Date: 01 January 2014

    Source: MEDLINE from PubMed

  47. 47. Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review.

    Author(s): Castilho JL, Melekhin VV, Sterling TR

    Citation: AIDS research and human retroviruses, May 2014, vol./is. 30/5(446-56), 0889-2229

    Publication Date: May 2014

    Source: MEDLINE from PubMed

  48. 48. Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.

    Author(s): Colombo GL, Castagna A, Di Matteo S, Galli L, Bruno G, Poli A, Salpietro S, Carbone A, Lazzarin A

    Citation: Therapeutics and clinical risk management, 2014(9-15), 1176-6336

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  49. 49. Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.

    Author(s): Cagigi A, Rinaldi S, Cotugno N, Manno EC, Santilli V, Mora N, Zangari P, Aquilani A, Tchidjou KH, Giaquinto C, Bernardi S, Rossi P, Palma P

    Citation: The Pediatric infectious disease journal, May 2014, vol./is. 33/5(e126-31), 0891-3668

    Publication Date: May 2014

    Source: MEDLINE from PubMed

  50. 50. Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique.

    Author(s): Palladino C, Briz V, Bellón JM, Bártolo I, Carvalho P, Camacho R, Muñoz-Fernández MÁ, Bastos R, Manuel R, Casanovas J, Taveira N

    Citation: PloS one, 2013, vol./is. 8/12(e82718),

    Publication Date: 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine


Results Selected
No results selected.

Output Format
Choose output document format.
Display Format
Choose output fields.
Actions
Display, save or email results with selected fields and output formats.